---
schema_version: "secwatch.filing_event.v1"
accession: "0001757073-22-000086"
form_type: "8-K"
ticker: "NVST"
cik: "0001757073"
company_name: "Envista Holdings Corp"
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:20:22.549872+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Envista Q2 sales $645.8M (+1.3%), core sales +4.0%; adj EPS $0.48; guidance revised to mid-single digits growth

## Summary
- Sales $645.8M (+1.3% YoY), core sales growth 4.0%; net income $44.5M ($0.25 diluted EPS).
- Adjusted net income $86.0M, adjusted EPS $0.48 (vs $0.46 in Q2 2021); adjusted EBITDA $126.9M, margin 19.7%.
- FY 2022 guidance: core sales growth revised to mid-single digits; maintains adjusted EBITDA margin target of 20%.
- Closed acquisitions of Carestream Dental's IOS business (Q2) and Osteogenics Regenerative Solutions (July).
- Cites headwinds: supply chain disruptions, inflation, geopolitical uncertainties, China COVID lockdown.

## SEC filing metadata
- accession: 0001757073-22-000086
- form_type: 8-K
- ticker: NVST
- cik: 0001757073
- company_name: Envista Holdings Corp
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757073/000175707322000086/0001757073-22-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757073/000175707322000086/nvst-20220803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757073-22-000086
- JSON: https://secwatch.observer/filing/0001757073-22-000086.json
- Plain text: https://secwatch.observer/filing/0001757073-22-000086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.